Blueprint Medicines shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Blueprint Medicines by Ubs Global Asset Management Americas
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $22M | 239k | 92.24 |
2023-09-30 | $12M | 242k | 50.22 |
2023-06-30 | $11M | 252k | 44.99 |
2023-03-31 | $11M | 252k | 44.99 |
2022-12-31 | $12M | 262k | 43.81 |
2022-09-30 | $18M | 269k | 65.89 |
2022-06-30 | $14M | 280k | 50.51 |
2022-03-31 | $15M | 240k | 63.88 |
2021-12-31 | $25M | 235k | 107.11 |
2021-09-30 | $27M | 261k | 102.81 |
2021-06-30 | $25M | 282k | 87.96 |
2021-03-31 | $25M | 258k | 97.23 |
2020-12-31 | $28M | 301k | 92.70 |
2020-09-30 | $28M | 301k | 92.70 |
2020-06-30 | $22M | 279k | 78.00 |
2020-03-31 | $5.4M | 92k | 58.48 |
2019-12-31 | $11M | 138k | 80.11 |
2019-09-30 | $10M | 136k | 73.47 |
2019-06-30 | $13M | 132k | 94.33 |
2019-03-31 | $10M | 130k | 80.05 |
2018-12-31 | $6.8M | 126k | 53.91 |
2018-09-30 | $10M | 134k | 78.06 |
2018-06-30 | $8.1M | 127k | 63.48 |
2018-03-31 | $9.9M | 108k | 91.70 |
2017-12-31 | $8.3M | 110k | 75.41 |
2017-09-30 | $7.6M | 109k | 69.67 |
2017-06-30 | $661k | 13k | 50.67 |
2017-03-31 | $201k | 5.0k | 39.99 |
2016-09-30 | $327k | 11k | 29.69 |
2016-06-30 | $205k | 10k | 20.30 |
2016-03-31 | $182k | 10k | 18.02 |
2015-12-31 | $3.3M | 124k | 26.34 |
2015-09-30 | $2.9M | 135k | 21.34 |
2015-06-30 | $3.2M | 119k | 26.49 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas